Updated: Jun 27, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
E Stoeckle1, A Italiano, N Stock
1Institut Bergonié, Centre régional de lutte contre le cancer, Bordeaux, France. stoeckle@bergonie.org
Adequate surgery margins are crucial for soft tissue sarcoma (STS) treatment, significantly reducing local recurrence (LR) rates. Specialized centers achieve better outcomes, with actuarial 5-year LR rates between 10-20% indicating good surgical quality.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: